From schools to shopping centers, gyms to swimming pools, to hotels and restaurants and on the road. Until now, it has not been possible to have non-medical personnel treat people who requiring immediate life saving ventilation at the scene of an emergency.
Biphasic Cuirass Ventilation (BCV) with the Hayek MRTX ventilator, delivers a comprehensive and effective solution to this problem by providing complete ventilation non-invasively, available to be applied immediately by non-medical personnel at the scene.
The Hayek MRTX uses a method known as Biphasic Cuirass Ventilation or BCV to provide complete, yet non-invasive ventilation for patients. This method of ventilation can be applied very easily and in a short learning time. Making it ideal for medical or non-medical personnel providing treatment at the scene. The short time required to apply BCV is crucial in emergency situations and can be the difference between life and death.
BCV actively controls both the inspiratory and expiratory phases of the respiratory cycle. Biphasic Cuirass Ventilation works physiologically by creating negative chamber pressure on the entire chest area. BCV causes the lungs to expand and for inhalation to occur. Using positive pressure in the cuirass, it then creates an expiratory, exhalation.
The patented technology used in the Hayek MRTX greatly increases minute ventilation and enables effective ventilation in both normal and injured lungs.
Additional benefits of BCV include the facilitation of secretion clearance and improvement of cardiac output during ventilation.
Plane, Trains, Automobiles and Public Places
As increasing numbers of people gather in shopping centers and stadiums, on public transportation, in high-rise buildings, and public places, the likelihood of emergency situations have dramatically risen. Increased traffic on the road, air, sea and rail has added to the realistic dangers faced by large groups of the public when traveling.
Serious falls at a play yard, choking in a restaurant, and accidents by pools, have raised awareness of the acute problem of treating and dealing with emergency situations.
During an emergency, many patients with respiratory failure who do not receive mechanical ventilation are likely to die. Biphasic Cuirass Ventilation and the Hayek MRTX provide a real answer to these real problems!
EMTs and Paramedics can easily use the Hayek MRTX on the scene of an emergency, in an ambulance or emergency response vehicle, on the go!
The Hayek MRTX is portable and can operate outside medical centers with no need for additional equipment. Once attached to an injured patient, it may accompany them until he or she reaches the hospital and obtains medical treatment with no need for additional intervention on route.
Ventilation may thus be initiated effectively during an emergency, continue on the way to the hospital, and save lives during those crucial moments by providing treatment before the patients condition deteriorates.
Police & Fire Rescue
In emergency response situations, prior to the arrival of the EMTs/Paramedics, some patients may require immediate life saving ventilation. From smoke inhalation to an unresponsive person, immediate life sustaining ventilation could be the difference between life and death.
With the Hayek MRTX and Biphasic Cuirass Ventilation, this real problem is solved. First responders to an emergency or accident, such as Police and Fire Rescue personnel can immediately apply Biphasic Cuirass Ventilation prior to the arrival of medical emergency responders.
A ventilator such as the Hayek MRTX delivers a comprehensive and effective solution by providing complete and non-invasive ventilation.
The MRTX utilizing Biphasic Cuirass Ventilation, or BCV, can be applied very easily and with an incredibly short learning time for the end user. Clinical studies have shown that the application of BCV with the Hayek MRTX can be taught in as little as 5 minutes, or simply by watching a short instructional video by virtually anyone.
Most importantly, in the unlikely event of misapplication of the Hayek MRTX, Biphasic Cuirass Ventilation carries absolutely no risk to the patient, unlike positive pressure ventilation, which may prove fatal.
The innovative MRTX leverages advanced technology, while designed in a way that doctors, nurses, health professionals and even non-clinical personnel can operate quickly without any special training. This makes it ideal for personnel providing rapid treatment at the scene of an emergency, while avoiding the difficulties and complication that will likely arise with invasive ventilation.
Biphasic Cuirass Ventilators, such as the Hayek MRTX are easily portable, are extremely lightweight, with a ruggedized case for outdoor use. The rechargeable battery of the Hayek MRTX provides full ventilation for up to 6 hours and can also run on 12 and 24 volts, as well as on mains power allowing the Hayek MRTX to be used for routine care as well. Preset ventilation parameters based on patient dimensions, eliminate any setting concerns.
With BCV, the goal of increasing the number of individuals trained or cross-trained to manage ventilator-dependent patients is easily achieved with the Hayek MRTX. The Hayek MRTX does not require skilled medical personnel.
The attached power unit actively controls both the inspiratory and expiratory phases of the respiratory cycle. Biphasic Cuirass Ventilation works physiologically. It operates externally by creating negative chamber pressure on the entire chest area. This causes the lungs to expand, and for inhalation to occur. Using positive pressure in the cuirass, it then creates an expiratory phase, exhalation.
BCV is easy to apply using the Hayek MRTX, even when cumbersome protective gear is worn; making it possible for one person to treat several patients. This is especially important where large numbers of people require emergency treatment.
The patented technology used in the Hayek MRTX greatly increases minute ventilation and enabling effective ventilation in both normal and injured lungs. Additional benefits of BCV include the facilitation of secretion clearance and improvement in cardiac output during ventilation.
The Hayek MRTX utilizing BCV is the only viable solution for providing ventilation in emergency situations.
The Hayek MRTX was designed to be manufactured very quickly in the event of a surge in the number of patients requiring ventilation.
With the appropriate cuirass shell, BCV can be used on anyone.
Positive pressure ventilation techniques, as well as invasive mechanical ventilation, have a lengthy list of adverse effects, which BCV does not. Some potential adverse physiologic effects of positive pressure ventilation (PPV) are:
Perhaps the most feared complications occurring during mechanical ventilation include:
The use of positive pressure ventilation can lead to barotrauma, volutrama and possible development of a pneumothorax. These complications can be entirely avoided with the use of BCV.
BCV offers effective, even and natural ventilation without risk to the patient and can be applied by virtually anyone with minimal training.
BCV will also facilitate the clearance of secretions in contrasts to PPV, which compounds secretions.
BCV provides the only real solution to the complexities encountered in delivering life saving ventilation in emergency military situations.
Application of a Cuirass and initiation of Biphasic Cuirass Ventilation by gear-protected physicians was investigated. In the study, 10 physicians of multiple specialties applied a cuirass shell on an adult patient. Biphasic Cuirass Ventilation was initiated using the Hayek RTX ventilator. ET intubation and manual ventilation of a mannequin were also reasonably evaluated.
In conclusion, physicians wearing full protective gear applied a cuirass shell and instituted Biphasic Cuirass Ventilation much quicker than ET intubation and manual positive pressure ventilation.
In another study Comparing the MRTX ventilator to positive pressure ventilation (PPV) in OP (paraoxon) poisoned pigs, three study groups were examined:
There were a total of 23 animals – two were used as controls to establish the specific respiratory insult model, seven in every other group. Each animal was exposed to 1.2LD50 of paraoxon IM Atropine was given IM eight minutes post exposure. After ventilation was stopped, the MRTX group started to breath freely and independently, in contrast to the PPV and control groups. Survival Rate in each group:
The effect of BCV for acute respiratory failure through the patient of pandemic A (H1N1) influenza infection was examined. BCV (Continuous Negative Mode: CNEP) was used as respiratory management in 4 cases, and BCV (Secretion Clearance Mode: SC) was used as airway clearance in 8 cases. All 4 BCV (CNEP) cases had pneumonitis, respiratory distress and severe hypoxia. In 3 cases using BCV (CNEP), atelectasis was present. BCV (SC) with BCV (CNEP) was used to clear their airway 3 or 4 times a day. The patients recovered without intratracheal intubation.
Overall, BCV was effective for pandemic A (H1N1) influenza. Especially, the direct effects that BCV (CNEP) provided from early respiratory distress, and as a result prevented serious illness. BCV (SC) prevented obstruction of the airways, and also aided patient’s to recover from marked obstructions (plastic bronchitis).